Bristol-Myers Squibb | BMY - Market Capitalization


Bristol-Myers Squibb reported $132.36B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Abbott USD 171.01B 12.96B Sep/2026
ALKERMES USD 7.39B 595M Nov/2026
Amgen USD 247.94B 20.06B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 2.29B 8.43B Nov/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Perrigo USD 2.17B 31M Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.2B 38M Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Sanofi EUR 114.34B 15.65B Nov/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
Zoetis USD 37.95B 9.1B Nov/2026